Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer

Corporate Breaking News

Home : Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer

Jan 06 2020	Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer
LEEDS, England, Jan. 6, 2020 /PRNewswire/ -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces the opening of a clinical study to evaluate the safety and preliminary clinical efficacy of MRx0518 in combination with...


Source:https://www.prnewswire.com:443/news-releases/clinical-update--4d-announce-new-study-of-mrx0518-in-pancreatic-cancer-300981352.html

Related News
» CarKitAI's Roxie Karaoke Car Entertainment Makes Road Trips and Commute Fun Again » Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.